Sort
50,496 grants matching “lung cancer”
Loss of NF1 drives hormone dependent mammary carcinogenesis in a rat model with intact immune system
$547,183Deeann Wallis-Schultz · University Of Alabama At Birmingham · R01 · FY2025 · CA
Targeting the vasculature to enhance anti-tumor immunity
$547,081Andrew Carl Dudley · University Of Virginia · R01 · FY2025 · CA
Role of miR155 in Leukemogenesis
$547,067Carlo M Croce · Ohio State University · R01 · FY2008 · CA
Optimization of small molecule integrin activators to enhance cord blood transplant
$547,028Peter Vanderslice · Texas Heart Institute · R33 · FY2022 · HL
Optimization of small molecule integrin activators to enhance cord blood transplant
$547,028Peter Vanderslice · Texas Heart Institute · R33 · FY2023 · HL
EZH2 in cancer biology and novel inhibitors
$546,990Jun Qi · Dana-Farber Cancer Inst · R01 · FY2018 · CA
Antibody Drug Conjugate (ADC) Workbench
$546,989Alison Mary Betts · Applied Biomath, Llc · R44 · FY2022 · GM
Antibody Drug Conjugate (ADC) Workbench
$546,989Alison Mary Betts · Applied Biomath, Llc · R44 · FY2021 · GM
Rapid and affordable magneto-nanosensors for ctDNA-guided lung cancer management
$546,948Shan X. Wang · Stanford University · R01 · FY2023 · CA
Regulation of Pre-mRNA Splicing in Tumorigenesis
$546,946Adrian R Krainer · Cold Spring Harbor Laboratory · P01 · FY2007 · CA
Mathematical modeling of metabolism rewiring in cancer eco-evolution and metastasis tropism
$546,896Joao Xavier · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Addressing racial disparities in lung cancer screening
$546,688Melinda Aldrich · Vanderbilt University Medical Center · R01 · FY2024 · CA
Copper-mediated metabolic reprogramming and ECM alterations in TNBC metastasis
$546,681Vivek Mittal · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA
Targeting iRhom to Improve Colon Cancer Immunochemotherapy
$546,625Song Li · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
Promoting hematopoietic regeneration after chemo by rescheduling homeostasis
$546,614Joseph Michael Scandura · Weill Medical Coll Of Cornell Univ · R56 · FY2014 · HL
Developing translationally-relevant genetically engineered mouse models of lung adenocarcinoma for investigations in cancer immunology
$546,612Nikhil Joshi · Yale University · R01 · FY2023 · CA
Activating Native Tumor Immunity with IL-33 Armored CARs
$546,511Yina Hsing Huang · Dartmouth College · R01 · FY2024 · CA
Infrastructure Support and Pilot Tissue Collection for the CARET Biorepository
$546,507Chu Chen · Fred Hutchinson Cancer Research Center · U01 · FY2019 · CA
Project 1: Systematic Physical and Spatial Mapping of Cancer Driver Networks
$546,481Emma Lundberg · University Of California, San Francisco · U54 · FY2025 · CA
Toward Clinical Trial: AXL-STAT3 Targeting of Lung Tumor Microenvironments
$546,433Josephine A Taverna · University Of Texas Hlth Science Center · R01 · FY2024 · CA
Therapeutic strategies against EGFR exon 20 mutant lung cancer
$546,332John V. Heymach · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Therapeutic strategies against EGFR exon 20 mutant lung cancer
$546,332John V. Heymach · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Targeted Radiotherapy of Neoplastic Meningitis using Monoclonal Antibodies Label
$546,302Michael Rod Zalutsky · Duke University · P01 · FY2015 · CA
Background free amplified single-molecule FISH for in situ and flow cytometric applications
$546,183Sanjay Tyagi · Rbhs-New Jersey Medical School · R01 · FY2022 · CA
Purine Synthesis Inhibitors with Selective Folate Receptor Tumor Transport
$546,172Aleem Gangjee · Duquesne University · R01 · FY2014 · CA